Tag: Daiichi Sankyo

Biopharma

Top 20 biopharma cos report fall in market capitalization

0
Expanding competition in the generic drugs segment and a decline in the demand for Covid-19 vaccines and therapies have brought down the aggregate market...

This function has been disabled for HealthTekPak.

error: Content is protected !!